Head & Neck Cancer, 23-24 September 2022, Singapore
Online application is open until 3 July 2022
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The leading professional organisation for medical oncology
Meet us in Paris to interact with key opinion leaders and learn first-hand about practice challenges and controversies in oncology
Online application is open until 3 July 2022
23-24 September 2022, Lisbon, Portugal
2-4 December: the leading oncology congress in Asia – Pacific is back in Singapore! Listen to Asian and international KOLs presenting their latest findings
Join the experts developing and implementing the ESMO Guidelines
A validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Now available on-demand. Take the CME test and advance your knowledge in upper digestive cancers
From ASCO 2022 Annual Meeting:
Preliminary findings indicate that patients with tumours harbouring NRG1 fusions may benefit from treatment with zenocutuzumab or seribantumab
Read more about how the global oncology community is responding to the humanitarian crisis
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.